Sumanta Kumar Pal, Laurence Albiges, Axel Bex, Cristina Suarez, Robert Uzzo, Xiaobin Tang, Sarita Dubey, Erik T. Goluboff, Corey Allan Carter, Wenxin Xu, Romain Banchereau, Mahrukh A. Huseni, Brian I. Rini. "Genomic characterization of baseline and post-progression tumors in IMmotion010, a randomized, phase 3 study of adjuvant (adj) atezolizumab (atezo) vs placebo (pbo) in patients (pts) with high-risk localized renal cell carcinoma (RCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4510